Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kathryn Dunne"'
Autor:
Alicia F. Okines, Houman Moghadam, Laura Sparks, Kabir Mohammed, Kathryn Dunne, Ashutosh Nerurkar, Peter Osin, Claire Swift, Ruth Sardinha, Nicholas Turner
Publikováno v:
Cancer Research. 83:P4-01
Background CDK4/6 inhibitors may trigger anti-tumour immunity, both through tumour cell intrinsic and extrinsic mechanisms, which can be enhanced by immune checkpoint blockade in pre-clinical studies. Although most triple negative breast cancers (TNB
Autor:
Maria Coakley, Prithika Sritharan, Guillermo Villacampa, Claire Swift, Kathryn Dunne, Lucy Kilburn, Katie Goddard, Patricia Rojas, Andy Joad, Warren Emmett, Charlene Knape, Karen Howarth, Peter S. Hall, Catherine Harper-Wynne, Tamas Hickish, Iain Macpherson, Alicia F. Okines, Andrew M. Wardley, Duncan Wheatley, Simon Waters, Rosalind Cutts, Isaac Garcia-Murillas, Judith Bliss, Nicholas Turner
Publikováno v:
Cancer Research. 83:PD5-03
Background: Detection of circulating tumour DNA (ctDNA) in patients (pts) who have completed treatment for early-stage breast cancer is associated with a high risk of future relapse. Identifying those at high risk of subsequent relapse may allow tail
Autor:
Isaac Garcia-Murillas, Giselle Walsh-Crestani, Edward Phillips, Rosalind Cutts, Sarah Hrebien, Kathryn Dunne, Kally Sidhu, Robert Daber, Amber C. Carter, Lorena De La Peña, Stephen Johnston, Alistair Ring, Simon Russell, Abigail Evans, Anthony Skene, Duncan Wheatley, Ian Smith, Nicholas Turner
Publikováno v:
Cancer Research. 83:P5-05
Introduction: Identification of Molecular Residual Disease (MRD) in patients with breast cancer with circulating tumor DNA (ctDNA) presents a strategy to identify patients at high risk of relapse. Approaches that detect ctDNA at lower concentrations
Autor:
Alistair E. Ring, Laura Moretti, Angelica Afshari-Mehr, Andrew M. Wardley, Lucy Kilburn, Bora Gurel, Iain R. MacPherson, Richard D. Baird, Sue Martin, Alex Pearson, Rebecca Roylance, Matthew Winter, Kathryn Dunne, Ellen Copson, Tamas Hickish, Peter Stephens, Russell J. Burcombe, Katrina Randle, Judith Bliss, Nicholas C. Turner
Publikováno v:
Journal of Clinical Oncology. 40:1024-1024
1024 Background: The plasmaMATCH trial was an open label platform trial, consisting of circulating tumour DNA (ctDNA) testing in ̃1000 patients with advanced breast cancer (ABC) linked to parallel treatment cohorts with therapies matched to mutation
Publikováno v:
Family Therapy in Global Humanitarian Contexts ISBN: 9783319392691
This chapter discusses the origin and progress of a family therapy trainee-driven group dedicated to learning more about global mental health. As practitioners in training, we are interested in the intersection of professional scholarship and practic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58741330ecc8b5d056674d92a97b6d4d
https://doi.org/10.1007/978-3-319-39271-4_11
https://doi.org/10.1007/978-3-319-39271-4_11
Autor:
Kathryn Dunne, Pamela Doherty
Publikováno v:
Continuing Education in Anaesthesia Critical Care & Pain. 11:82-86
With the advent of organ transplantation, patients suffering from end-stage organ failure no longer face inevitable death or a lifetime of complex medical care and those receiving a transplanted organ can often return to a normal lifestyle. As a resu
Autor:
Chris Cairns, Kathryn Dunne
Publikováno v:
Journal of the Intensive Care Society. 14:174-175
Compared with placebo, Drotecogin alpha (activated) offers no mortality benefit at either 28 or 90 days in critically ill adults with septic shock. Level of evidence: 1B (well designed RCT)